Stempoint Capital’s Arrowhead Research ARWR Stock Holding History

Stempoint Capital’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,038	Closed	-$1.81M	–	69
2023 Q4	$1.81M	Buy	+59,038	New	+$1.57M	0.48%	51

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Stempoint Capital's ARWR Position: Q1 2024 in Review

Stempoint Capital sold out of Arrowhead Research (ARWR) in Q1 2024, closing a stake of 59,038 shares — an estimated $1.81M sold.

Stempoint Capital first reported a position in ARWR in Q4 2023 and held it in 1 quarter. The position peaked at $1.81M in Q4 2023. 274 funds tracked by Wall St. Rank hold ARWR as of Q1 2024.

Stempoint Capital reported no remaining Arrowhead Research position as of Q1 2024 after selling out during the quarter.
Stempoint Capital sold 59,038 Arrowhead Research shares in Q1 2024, an estimated $1.81M.
Stempoint Capital first reported a position in Arrowhead Research in Q4 2023 and held it in 1 quarter.
Stempoint Capital's Arrowhead Research position peaked at $1.81M in Q4 2023.
274 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2024.

Based on Stempoint Capital's 13F filing for Q1 2024, filed 14 May 2024.